OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
57
Results
Show all
Save search
Copy query
Show results for
Unknown
(55)
Proteomics
(2)
Organisms
Homo sapiens
(2)
Repository
pride
(2)
Tissue
T cell
(2)
Blood
(1)
Disease
Neurodevelopmental delay
(1)
Technology Type
Mass Spectrometry
(2)
Affinity proteomics
(1)
All-ion fragmentation
(1)
Bottom-up proteomics
(1)
Data-independent acquisition
(1)
DiaPASEF
(1)
Publication Date
2025
(2)
Release Date
2019
(11)
2021
(9)
2017
(7)
2025
(6)
2020
(6)
2023
(5)
2018
(3)
2016
(3)
2026
(1)
2022
(1)
2015
(1)
2014
(1)
2013
(1)
Lab affiliation
95 Institut de Pharmacologie et de Biologie Structurale (IPBS), Université de Toulouse, CNRS, Université Toulouse III - Paul Sabatier (UT3), Toulouse, 31077, France
(1)
Universitätsmedizin Greifswald Interfakultäres Institut für Genetik und Funktionelle Genomforschung Abteilung für Funktionelle Genomforschung Felix-Hausdorff-Straße 8 17487 Greifswald
(1)
Previous
page
1 / 6
You're on page
1
page
2
page
3
page
4
page
5
page
6
Next
page
Sort
by:
Relevance
Page size
10
Gain-of-function mutations in KCNK3 cause a developmental disorder with sleep apnea.
Not available
S-EPMC9534757
|
biostudies-literature
Cite
Efficacy and Safety of IDegLira in Participants with Type 2 Diabetes in India Uncontrolled on Oral Antidiabetic Drugs and Basal Insulin: Data from the DUAL Clinical Trial Program.
Not available
S-EPMC5446379
|
biostudies-literature
Cite
A Fixed Ratio Combination of Insulin Degludec and Liraglutide (IDegLira) Reduces Glycemic Fluctuation and Brings More Patients with Type 2 Diabetes Within Blood Glucose Target Ranges.
Not available
S-EPMC5399738
|
biostudies-literature
Cite
Synthesis and structure-activity relationships of N-benzyl phenethylamines as 5-HT2A/2C agonists.
Not available
S-EPMC3963123
|
biostudies-literature
Cite
Insulin degludec/liraglutide (IDegLira) maintains glycaemic control and improves clinical outcomes, regardless of pre-trial insulin dose, in people with type 2 diabetes that is uncontrolled on basal insulin.
Not available
S-EPMC7003817
|
biostudies-literature
Cite
Superior efficacy of insulin degludec/liraglutide versus insulin glargine U100 as add-on to sodium-glucose co-transporter-2 inhibitor therapy: A randomized clinical trial in people with uncontrolled type 2 diabetes.
Not available
S-EPMC6593861
|
biostudies-literature
Cite
Occupational risk of COVID-19 related hospital admission in Skane, Sweden: A register-based cohort study.
Not available
S-EPMC12585036
|
biostudies-literature
Cite
Rationale and design of the phase 3a development programme (ONWARDS 1-6 trials) investigating once-weekly insulin icodec in diabetes.
Not available
S-EPMC10092674
|
biostudies-literature
Cite
Multiscore, a gene ranker powered by artificial intelligence and real-world clinical data, shows high sensitivity for the molecular diagnosis of Mendelian disorders in nearly 10,000 exomes and genomes.
Not available
S-EPMC12909342
|
biostudies-literature
Cite
TRPV6 Variants Interfere with Maternal-Fetal Calcium Transport through the Placenta and Cause Transient Neonatal Hyperparathyroidism.
Not available
S-EPMC5992228
|
biostudies-literature
Cite
Previous
page
1 / 6
You're on page
1
page
2
page
3
page
4
page
5
page
6
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets
